Enanta Pharmaceuticals | ENTA - Attività





Attività Cambiamento Data
AbbVie USD 147.68B 12.57B 2026-09
Amgen USD 95.64B 3.14B 2026-06
Anika Therapeutics USD 183.47M 4.09M 2026-06
Arrowhead Research USD 2.11B 156.25M 2026-06
AstraZeneca USD 119.92B 4.09B 2026-09
BioCryst Pharmaceuticals USD 557.85M 92.8M 2026-06
Biogen USD 32.05B 32.5M 2026-09
Bristol-Myers Squibb USD 88.77B 1.14B 2026-09
Enanta Pharmaceuticals USD 329.5M 48.77M 2025-12
Gilead Sciences USD 51.41B 2.05B 2026-09
GlaxoSmithKline GBP 71.7B 9.96B 2026-09
Halozyme Therapeutics USD 2.58B 95.31M 2026-06
Heron Therapeutics USD 252.26M 6.05M 2026-06
Immunic USD 189.74M 165.69M 2026-03
Incyte USD 7.29B 585.39M 2026-09
Insmed USD 2.23B 123.49M 2026-09
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
J&J USD 197.42B 3.64B 2026-09
Karyopharm Therapeutics USD 131.42M 23M 2026-03
Ligand Pharmaceuticals USD 2.24B 51.59M 2026-09
Merck USD 129.8B 1.12B 2026-06
Neurocrine Biosciences USD 5.63B 268.3M 2026-09
Novartis USD 117.15B 4.88B 2026-09
Novavax USD 955.58M 87.59M 2026-06
Pfizer USD 204.54B 3.41B 2026-09
PTC Therapeutics USD 3.21B 42.76M 2026-09
Roche Holding CHF 98.2B 2.5B 2026-06
Sarepta Therapeutics USD 3.19B 9.58M 2026-06
Vertex Pharmaceuticals USD 32.74B 5.31B 2026-09